Evaluation of efficacy and safety of upfront weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer

Akira Matsui, Akihiko Tatibana, Noriyuki Suzuki, Masaru Hirata, Yoko Oishi, Youhei Hamaguchi, Yuya Murata, Aiko Nagayama, Yuko Iwata, Yasushi Okamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Evaluation of efficacy and safety of upfront weekly nanoparticle albumin-bound paclitaxel for HER2-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences